The role of thrombolytic therapy in the management of acute and chronic lower extremity ischemia

Journal of Endovascular Therapy

Volumn 7, Issue 1, 2000, Pages 72-77

  Greenberg, R ^a   Ouriel, K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; UROKINASE;

ACUTE DISEASE; ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; CARDIOPULMONARY INSUFFICIENCY; CHRONIC DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HUMAN; LEG ISCHEMIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0033898382     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2000)007<0072:trotti>2.3.co;2     Document Type: Article

References (11)

1. Selective clot lysis with low-dose streptokinase
2. Thrombolysis of peripheral and arterial graft occlusions: Improved results using high-dose urokinase
3. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia
4. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremities
5. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: Results of a prospective randomized trial
6. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts
7. Acute lower limb ischemia: Determinants of outcome
8. Thrombolysis or peripheral arterial surgery: Phase I results
9. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs
10. Current status of percutaneous mechanical thrombectomy. Part II. Devices and mechanism of action
11. Mechanical versus chemical thrombolysis: An in vitro differentiation of thrombolytic mechanism